Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sepulveda

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Brain Communications|October 20, 2025
Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteriaMaria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl, et al.
AJNR. American Journal of Neuroradiology|December 31, 2011
The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomasA Hilario, A Ramos, A Perez-Nuñez, et al.
Neuro-Oncology|February 27, 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastomaSara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, et al.
Theranostics|January 2, 2025
S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architectureBlanca Cómitre-Mariano, Berta Segura-Collar, Gabriel Vellila-Alonso, et al.
Journal of Molecular and Cellular Cardiology|May 7, 2013
Anti-hypertrophic and anti-oxidant effect of beta3-adrenergic stimulation in myocytes requires differential neuronal NOS phosphorylationVabren L Watts, Fernando M Sepulveda, Oscar H Cingolani, et al.
Transplantation Proceedings|March 28, 2018
Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant CenterL A Caicedo, A Delgado, V H Garcia, et al.
Cardiovascular Toxicology|December 10, 2014
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose StudyRichard J Kovacs, Giuliana Maldonado, Analia Azaro, et al.
Cancer Treatment Reviews|January 16, 2021
Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near futureM Rey-Cárdenas, F Guerrero-Ramos, A Gómez de Liaño Lista, et al.
Scientific Reports|March 2, 2023
Diffusion tensor imaging metrics associated with future disability in multiple sclerosisE Lopez-Soley, E Martinez-Heras, E Solana, et al.
Investigational New Drugs|December 23, 2014
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancerJordi Rodón, Michael Carducci, Juan M Sepulveda-Sánchez, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Brain Communications|October 20, 2025
Oligodendrogliomas, cyclin pathway after the introduction of the molecular 2021 World Health Organization (WHO) criteriaMaria Angeles Vaz-Salgado, Juan M Sepulveda, Julie Earl, et al.
AJNR. American Journal of Neuroradiology|December 31, 2011
The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomasA Hilario, A Ramos, A Perez-Nuñez, et al.
Neuro-Oncology|February 27, 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastomaSara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, et al.
Theranostics|January 2, 2025
S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architectureBlanca Cómitre-Mariano, Berta Segura-Collar, Gabriel Vellila-Alonso, et al.
Journal of Molecular and Cellular Cardiology|May 7, 2013
Anti-hypertrophic and anti-oxidant effect of beta3-adrenergic stimulation in myocytes requires differential neuronal NOS phosphorylationVabren L Watts, Fernando M Sepulveda, Oscar H Cingolani, et al.
Transplantation Proceedings|March 28, 2018
Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant CenterL A Caicedo, A Delgado, V H Garcia, et al.
Cardiovascular Toxicology|December 10, 2014
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose StudyRichard J Kovacs, Giuliana Maldonado, Analia Azaro, et al.
Cancer Treatment Reviews|January 16, 2021
Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near futureM Rey-Cárdenas, F Guerrero-Ramos, A Gómez de Liaño Lista, et al.
Scientific Reports|March 2, 2023
Diffusion tensor imaging metrics associated with future disability in multiple sclerosisE Lopez-Soley, E Martinez-Heras, E Solana, et al.
Investigational New Drugs|December 23, 2014
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancerJordi Rodón, Michael Carducci, Juan M Sepulveda-Sánchez, et al.
Pageof 7